Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse
-
745 Capital Commences Tender Offer for Senior Notes
-
Oxford Lane (OXLC) Prices Preferred Stock Offering
-
Oxford Lane Capital Corp. Prices Preferred Stock Offering
-
Oxford Lane (OXLC) Announces Preferred Stock Offering
-
Oxford Lane Capital Corp. Announces Preferred Stock Offering
-
Great Elm Group, Inc. Prices Public Offering of $25,000,000 of 7.25% Notes Due 2027
-
Great Elm Group Announces Public Offering of Unsecured Notes
-
Sachem Capital Corp. Announces Sale of an Additional $2.5 Million of 7.125% Notes from Exercise of Over Allotment Option
-
Advisor Group Welcomes IronBridge Wealth Counsel To Its Network
-
Top Penny Stocks Today: What's Moving AVDL, BKSY, NILE, INO, & ALLR
-
Metal Sky Star Acquisition Corporation Announces the Separate Trading of its Ordinary Shares, Rights and Warrants
-
Advisor Group Accelerates Growth and Expands Multi-Channel Leadership with Acquisition of Infinex Financial Holdings, with over $30 Billion in Assets
-
Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
-
Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
-
Vallon Pharmaceuticals Inc. (VLON) Prices 3.7M Share Offering at $1.06/sh
-
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
-
Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering
-
TAG Investment Bankers Ltd. Issues Analyst Report on Jaguar Health
-
Sachem Capital Corp. Announces Closing of Public Offering of $27.5 Million of 7.125% Notes
-
Saratoga Investment Corp. Announces Exercise and Closing of Underwriters’ Option to Purchase Additional 6.00% Notes Due 2027
-
Saratoga Investment Corp. Announces Exercise and Closing of Underwriters’ Option to Purchase Additional 6.00% Notes Due 2027
-
Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
-
Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
-
Advisor Group Continues To Grow and Build On Its Strategic Vision With Addition Of Experienced Business Strategist and Compliance Expert
-
Sachem Capital Corp. (SACH) Prices $27.5M Notes Offering
-
Sachem Capital Corp. Prices Registered Public Offering of $27.5 Million of 7.125% Notes
-
Palisade Bio Inc. (PALI) Announces 3.65M Share Direct Offering at $0.55/sh
-
Palisade Bio Announces $2.0 Million Registered Direct Offering
-
Arca Biopharma (ABIO) Retains Ladenburg Thalmann to Support Strategic Options Review
-
ARCA biopharma Retains Ladenburg Thalmann to Support Strategic Options Review
-
Advisor Group Selects CAIS for Alternative Investment Access and Education
-
Sachem Capital Corp. (SACH) Announces Registered Public Offering of Notes
-
Sachem Capital Corp. Announces Registered Public Offering of Notes
-
Saratoga Investment Corp. Announces Fiscal Year-End and Fourth Quarter 2022 Financial Results
-
Form 13F-NT LADENBURG THALMANN ASSET For: Mar 31
-
Peak Bio to Go Public Via Merger with Ignyte Acquisition Corp (IGNY) in $278M Deal
-
Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company
-
SCYNEXIS Announces Closing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
-
Replays Available from the Influential Companies of the 2022 Sequire Cannabis and Psychedelic Conference
-
Chicken Soup for the Soul Entertainment Announces the Closing of $10,400,000 Principal Amount of Notes Due 2025
-
Chicken Soup for the Soul Entertainment Announces the Closing of $10,400,000 Principal Amount of Notes Due 2025
-
Salarius Pharmaceuticals, Inc. (SLRX) Prices 9.34M Share Direct Offering at $0.25/sh
-
Salarius Pharmaceuticals, Inc. Announces $2.3 Million Registered Direct Offering
-
Scynexis (SCYX) Prices $45M Stock and Warrant Offering at $3/sh
-
SCYNEXIS Announces Pricing of $45 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants
-
Vallon Pharmaceuticals Inc. (VLON) Announces Review of Strategic Alternatives
-
Vallon Pharmaceuticals Announces Review of Strategic Alternatives
-
Vallon Pharmaceuticals Announces Review of Strategic Alternatives
-
CSS Entertainment (CSSE) Prices $10.4M Notes Offering

